Running Rapamycin (Sirolimus)
Taking rapamycin off-label on a weekly or intermittent longevity protocol.
- Tests9
- With code$175.05
Order it in one cart
One draw at a Quest lab near you, no doctor’s visit. The prices are Marek’s own, with code CAMERON applied.
$175.05$194.50with code CAMERON
Drawn at any Quest location in the US, no doctor’s visit (not NY, NJ or RI). Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
What is in it
9 tests: $194.50 before the code, $175.05 with code CAMERON. Every marker links to its own free page.

The free Before‑You‑Stack Lab Kit
The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
Before you order
Why these markers
Who it is for, what it answers, what most people miss
- Who it is for
Taking rapamycin off-label on a weekly or intermittent longevity protocol. This panel exists because the compound is being used outside the setting its evidence comes from, and almost everything that matters about it is measurable.
- What it answers
Rapamycin is an mTOR inhibitor with a well-characterized adverse-effect profile from decades of transplant use: raised triglycerides and cholesterol, blood count suppression, impaired glucose handling and protein in the urine. Weekly low-dose protocols are a different exposure from daily transplant dosing, but they are not a different drug — and the exposure itself varies enormously between people on the same milligram dose. This panel measures both the drug and the four systems it moves.
- What most people miss
The blood level is the marker nobody orders and the only one that says whether the product is real. Rapamycin absorption varies several-fold between individuals on identical doses, and it is a gray-market purchase for most people using it this way. A whole-blood level answers two questions at once: whether what you took contains what it claims, and what exposure your protocol actually produces in you rather than in a study population. The lipids are the expected finding, not the alarming one. Raised triglycerides on an mTOR inhibitor is the most reproducible laboratory effect in the class. It is a reason to measure, adjust and re-measure — not a reason to panic on a first result.
How to prepare, and what skews it
30 things can skew it
When and how to get it drawn
Fast 9-12 hours for the lipids, insulin and HbA1c. The sirolimus level is a trough: draw it immediately before your next dose, not after one. A level drawn the day after a weekly dose is not comparable to anything and cannot be used to adjust. Record the exact hours since the last dose on the requisition — without that number the level is uninterpretable. Do not draw within 2 weeks of an infection; this class suppresses the blood count and CRP at the same time.
What skews the result
Some of these change your real level; others only change the reading. Each one says what to do.
- Acute illness or infectionPhysiological state
This is an acute-phase reactant — it moves substantially during any infection, injury or inflammatory episode, and the change has nothing to do with your baseline.
Do this: Wait two weeks after any illness, vaccination or injury before drawing or interpreting.
Affects: Complete Blood Count (CBC) with Differential, hs-CRP (High-Sensitivity C-Reactive Protein)- Fasting stateTiming
Less affected by eating than a calculated LDL, which is one of its advantages — but it still shifts modestly.
Do this: Fasted is preferable; consistency matters more.
Affects: ApoB (Apolipoprotein B), Fasting Insulin- Hemolysis (burst red cells)Assay
Red cells rupturing in the tube spill their contents into the serum. Potassium, LDH, AST and magnesium are far higher inside cells than outside, so a hemolyzed sample reports them falsely high. Caused by a difficult draw, a narrow needle, or shaking the tube.
Do this: The lab usually flags it. If your result is odd and the report mentions hemolysis, that is your answer — repeat the draw.
Affects: Comprehensive Metabolic Panel (CMP), Fasting Insulin- Recent hard trainingPhysiological state
Muscle damage and the inflammatory response to hard exercise shift this for days afterwards.
Do this: No hard or unfamiliar training for 48–72 hours before the draw.
Affects: Comprehensive Metabolic Panel (CMP), hs-CRP (High-Sensitivity C-Reactive Protein)- Recent exercisePhysiological state
Improves insulin sensitivity acutely for up to 48 hours, so a draw the morning after training flatters the number.
Do this: Consistent conditions matter more than good ones — same routine every retest.
Affects: Fasting Insulin, Urinalysis, Routine- Trough timingTiming
Reported against a trough range. Timing relative to the dose is the single largest determinant of the number.
Do this: Draw immediately before the next dose.
Affects: Sirolimus (Rapamycin), Whole Blood- CYP3A4 interactionsDrug or supplement
Grapefruit, clarithromycin, azole antifungals and many others raise levels substantially; rifampicin and St John's Wort lower them.
Do this: This is a narrow-window drug — any new medication or supplement needs prescriber review.
Affects: Sirolimus (Rapamycin), Whole Blood- DehydrationPhysiological state
Concentrates the blood and falsely raises hemoglobin, hematocrit and red cell count. Genuinely important on TRT, where a hematocrit near the ceiling changes management.
Do this: Hydrate normally the day before. Do not over-drink immediately before either — that dilutes in the other direction.
Affects: Complete Blood Count (CBC) with Differential- Recent hard training or endurance sportPhysiological state
Plasma volume expands with endurance training, diluting hemoglobin — 'athlete's pseudoanemia', which is an adaptation and not a deficiency. White cells also rise acutely after hard exercise.
Do this: Distinguish it by a normal ferritin. Draw 48–72 hours after hard work.
Affects: Complete Blood Count (CBC) with Differential- Delay before the sample is runSample prep
Platelet clumping in the EDTA tube produces a falsely low platelet count, and cells swell over time, shifting indices.
Do this: A surprisingly low platelet count with no symptoms is usually clumping. Ask for a citrate tube repeat.
Affects: Complete Blood Count (CBC) with Differential- Fasting vs non-fastingTiming
Triglycerides rise substantially after eating; total and HDL cholesterol barely move. Because LDL is usually calculated from triglycerides, a non-fasted draw distorts the LDL too — and the error is worst in exactly the people with high triglycerides.
Do this: Fast 10–12 hours if LDL matters. Guidelines increasingly accept non-fasting lipids, but be consistent between tests.
Affects: Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)- Recent illness, injury or surgeryPhysiological state
Cholesterol falls during acute illness and can stay low for weeks — a lipid panel after a hospital admission understates your true level.
Do this: Wait six weeks after any significant illness or surgery.
Affects: Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)- Acute weight loss or a very low-carbohydrate dietPhysiological state
Active fat loss mobilizes lipids and can transiently raise LDL. Some people show a striking LDL rise on ketogenic diets.
Do this: Measure at weight stability, not mid-cut.
Affects: Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)- Testosterone and anabolic steroidsDrug or supplement
Lower HDL substantially, and oral 17-alpha-alkylated compounds do so dramatically.
Do this: Expect it on TRT; note it rather than being alarmed by it in isolation.
Affects: Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)- Acute illnessPhysiological state
ApoB falls during acute illness along with the rest of the lipid panel, so a post-admission draw understates your true particle count.
Do this: Wait six weeks after anything significant.
Affects: ApoB (Apolipoprotein B)- Statins, ezetimibe, PCSK9 inhibitorsDrug or supplement
All lower ApoB, which is the point. The interference is in interpretation — a good ApoB on treatment is not the same as a good untreated one.
Do this: Record what you were taking at each draw.
Affects: ApoB (Apolipoprotein B)- Fist clenching and tourniquet timeSample prep
Clenching your fist pumps potassium out of muscle and can raise a measured potassium enough to trigger a false alarm. A long tourniquet concentrates protein, calcium and everything protein-bound.
Do this: Do not pump your fist. Ask for the tourniquet to come off early. An isolated high potassium with no symptoms is usually this.
Affects: Comprehensive Metabolic Panel (CMP)- Creatine supplementationDrug or supplement
Raises creatinine — a breakdown product of creatine — without harming the kidney at all. This is one of the most common false alarms in this audience, and it also drags the calculated eGFR down.
Do this: Expect it if you supplement creatine or carry muscle. Cystatin C settles it, because it is independent of muscle.
Affects: Comprehensive Metabolic Panel (CMP)- Anything that shortens red cell lifespanAssay
HbA1c measures glucose stuck to hemoglobin over the red cell's lifespan. Hemolysis, recent blood loss, recent transfusion or erythropoietin all shorten that lifespan and give the sugar less time to attach — producing a falsely LOW HbA1c in someone whose glucose control is actually poor.
Do this: If you are anemic, have donated blood recently, or are on TRT with a high hematocrit, read HbA1c alongside fasting glucose and fructosamine.
Affects: HbA1c (Hemoglobin A1c)- Iron deficiencyAssay
Raises HbA1c independently of glucose — older red cells accumulate more glycation. Correcting iron deficiency lowers HbA1c with no change in diet at all.
Do this: Check ferritin before acting on a borderline HbA1c.
Affects: HbA1c (Hemoglobin A1c)- Hemoglobin variantsAssay
Sickle trait, HbC and thalassemia interfere with several HbA1c methods, in either direction depending on the assay.
Do this: Relevant if you have African, Mediterranean, Middle Eastern or South Asian ancestry. Ask which method the lab uses.
Affects: HbA1c (Hemoglobin A1c)- CorticosteroidsPhysiological state
Raise glucose and white cells; suppress your own cortisol and ACTH production.
Do this: Note recent steroid use — including injections — when interpreting. Never stop long-term steroids abruptly.
Affects: HbA1c (Hemoglobin A1c)- Blood donation / phlebotomyPhysiological state
Lowers ferritin substantially; can falsely lower HbA1c by shortening red cell lifespan.
Do this: Track ferritin every time you donate — the classic TRT trap. Note recent donation when reading HbA1c.
Affects: HbA1c (Hemoglobin A1c)- Recent carbohydrateTiming
Insulin responds within minutes to eating. Even a coffee with milk the morning of the draw will move it, and it is far more sensitive to this than glucose.
Do this: 12 hours fasted, water only. This marker is unusually unforgiving.
Affects: Fasting Insulin- Menstruation and hydrationTiming
Menstrual blood contaminates the sample. Over-hydration dilutes everything toward false negatives.
Do this: Avoid testing during a period. First morning sample is the most concentrated and informative.
Affects: Urinalysis, Routine- Vitamin C and some drugsDrug or supplement
High-dose vitamin C causes false negatives for blood and glucose on dipstick. Rifampicin and phenazopyridine discolor urine enough to confuse the pads.
Do this: Stop high-dose vitamin C 48 hours before.
Affects: Urinalysis, Routine- Oral estrogen and hormonal contraceptivesDrug or supplement
They raise CRP through hepatic protein synthesis without any true increase in inflammation. This is the single most common reason a young healthy woman gets an alarming hs-CRP.
Do this: Note the contraceptive on the requisition and interpret hs-CRP against that, not against the standard risk bands.
Affects: hs-CRP (High-Sensitivity C-Reactive Protein)- Anything that inflamed you in the last two weeksTiming
hs-CRP is measuring the slow burn, but it cannot tell that apart from a cold, a dental infection, a vaccination or a brutal training session three days ago. Those push it into the high-risk band transiently and it reads identically.
Do this: If hs-CRP is high, repeat it two to four weeks later while well. One elevated reading is not a cardiovascular risk signal — a persistently elevated one is.
Affects: hs-CRP (High-Sensitivity C-Reactive Protein)- Statins, NSAIDs, corticosteroidsDrug or supplement
All lower CRP, so a treated value understates the underlying inflammatory state.
Do this: Note what you were taking. Avoid NSAIDs for a few days if the question is baseline inflammation.
Affects: hs-CRP (High-Sensitivity C-Reactive Protein)- Biological variabilityPhysiological state
hs-CRP varies substantially in the same person week to week. A single value is a poor baseline.
Do this: Take two readings a fortnight apart and use the lower, or the average.
Affects: hs-CRP (High-Sensitivity C-Reactive Protein)
How to read it
What the results can and cannot tell you, with sources
Expected and manageable: triglycerides and ApoB up, a mild fall in white cells or platelets, unchanged glucose. Worth acting on: a platelet count falling across two draws, new protein in the urine, a fasting insulin and HbA1c rising together, or mouth ulcers that keep recurring. A drug level far below what the dose predicts usually means the product, not the person — and a level far above it means the dose interval is wrong for you, which is the single most useful thing this panel can tell somebody.
What this panel can and cannot settle
What this panel can settle, and by what logic
Nine markers, and one of them is a category the rest of this site does not contain: a measurement of the drug itself rather than of its consequences.
- The whole-blood sirolimus level answers two questions at once and nothing else on the panel answers either. First, whether the product contains what it claims. Second, what exposure your dose produces in you. Both matter because the relationship is not fixed: in a real-world cohort taking low-dose rapamycin for longevity, dose-to-blood-level relationships were linear for both formulations studied, but compounded rapamycin was estimated at 31.03% of the bioavailability of the same milligram dose of the commercial product Harinath 2025. A dose number without a level is therefore not a protocol, it is a guess about absorption.
- The Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) and ApoB (Apolipoprotein B) read the most reproducible laboratory effect of the class. mTOR inhibition raises triglycerides and cholesterol, and it is the finding transplant medicine has documented longest Hands 2025. ApoB is on the panel rather than LDL alone because it counts atherogenic particles instead of estimating the cholesterol inside them, and the two diverge in precisely the metabolic state this drug can create Johannesen 2021.
- The Complete Blood Count (CBC) with Differential reads the second most reliable one. Cytopenias are a known class effect and the platelet count is usually the first to move, which is why a baseline before the first dose is worth more than any single later value.
- Fasting Insulin beside HbA1c (Hemoglobin A1c) catches the glucose effect in the right order. mTOR inhibition impairs insulin sensitivity with chronic exposure; fasting insulin moves months before HbA1c does, so the pair reads the trend rather than the endpoint.
- hs-CRP (High-Sensitivity C-Reactive Protein) is both the safety context for the blood count and the marker most often named as the intended benefit, which makes it the one number on the panel that could falsify the reason for taking the drug Luo 2023.
What the combination settles that no single marker does: whether an abnormal lipid or blood count belongs to your dose or to your exposure. A high triglyceride with a level at the bottom of the measurable range is a different problem from the same triglyceride with a level three times higher than the dose predicts.
What it cannot settle, and what would
It cannot tell you whether rapamycin is extending your healthspan, and no panel can. The human evidence for the longevity use is small, short and mostly uncontrolled, which is the conclusion of the review written to assess exactly that question Hands 2025. The largest dedicated trial in healthy adults reported changes in lean tissue mass and self-reported pain in women, and in emotional well-being and general health, over one year at the intermittent low exposures it tested Moel 2025. Those are outcomes measured on people, not markers on a panel.
It cannot detect the adverse effects that matter most in practice, because they are not in blood. Mouth ulcers, delayed wound healing and susceptibility to infection are the commonly reported ones and every one of them is observed rather than measured Hands 2025. A panel that comes back clean while you are getting recurrent mouth ulcers has not overruled the ulcers.
It cannot give you a target range. Whole-blood trough targets exist for transplant immunosuppression and are not transferable to weekly low-dose use, where no validated therapeutic window has been established Harinath 2025. The level is useful as your own baseline and for comparing formulations, not for hitting a published number.
And it is not a substitute for a prescriber. This is a prescription immunosuppressant being used off-label. The panel is a safety instrument for somebody who has already made that decision, and it does not make the decision.
Draw conditions that decide whether the money is wasted
Four conditions.
- Draw the sirolimus level as a trough, immediately before your next dose, and write the exact hours since the last dose on the requisition. A level taken the day after a weekly dose is measuring a different point on the curve and is comparable to nothing, including your own next result. Dose-to-level relationships are only interpretable when the sampling time is fixed Harinath 2025.
- Fast 9 to 12 hours for the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), ApoB (Apolipoprotein B), Fasting Insulin and HbA1c (Hemoglobin A1c). Triglycerides are the marker this drug moves and the marker a non-fasting draw distorts most.
- Not within 2 weeks of an infection. This class suppresses the blood count and this panel is trying to attribute a low count to the drug; an infection moves the Complete Blood Count (CBC) with Differential and hs-CRP (High-Sensitivity C-Reactive Protein) together and makes the attribution impossible Luo 2023.
- Take the same formulation you have been taking. Switching between commercial and compounded product between draws changes the exposure by several fold at an identical milligram dose Harinath 2025, so a level compared across a formulation change measures the pharmacy rather than you.
How you would know it answered your question, and what each pattern means next
Five results and what each one changes.
- Triglycerides and ApoB (Apolipoprotein B) up, Complete Blood Count (CBC) with Differential and Urinalysis, Routine normal: the expected finding. Address it as a lipid problem and retest the Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) and ApoB at 12 weeks, which is the interval at which a dietary or pharmacological lipid change has reached its plateau Johannesen 2021.
- A falling platelet count across two draws: the class effect that warrants a dose conversation rather than a wait. Recheck the Complete Blood Count (CBC) with Differential at 4 weeks, since platelet turnover is about 8 to 10 days and a trend is visible quickly.
- New protein on Urinalysis, Routine: repeat it before concluding anything, then take it to a clinician with the Comprehensive Metabolic Panel (CMP) Hands 2025.
- Fasting Insulin rising with HbA1c (Hemoglobin A1c) flat: the early half of the glucose effect. Recheck both at 12 weeks; HbA1c reflects roughly the preceding 3 months, so a shorter interval reads the old value.
- A sirolimus level far below what the dose predicts: suspect the product before suspecting yourself, particularly with a compounded formulation Harinath 2025. Far above it means the interval is wrong for your absorption, which is the single most actionable thing this panel can return.
And the falsification: if hs-CRP (High-Sensitivity C-Reactive Protein) does not fall and nothing else moves across a year, the honest reading is that the protocol is not doing anything measurable in you Hands 2025.
Sources read for these sections
- Hands JM, et al. What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. Aging (Albany NY) 2025 · PMID 40778880
- Moel M, et al. Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Aging (Albany NY) 2025 · PMID 40188830
- Harinath G, et al. The bioavailability and blood levels of low-dose rapamycin for longevity in real-world cohorts of normative aging individuals. GeroScience 2025 · PMID 39873920
- Johannesen CDL, et al. Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients. Journal of the American College of Cardiology 2021 · PMID 33736827
- Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034
Patterns, and where the results go
4 patterns, goals and what moves these markers
Patterns these markers can make
- The earliest metabolic warning — years before diabetes
Fasting insulin high · SHBG low · Triglyceride:HDL >3 · Glucose and HbA1c still 'normal'
Classic compensated insulin resistance. Your pancreas is working overtime to keep glucose normal — so the standard screening tests look fine while the underlying problem builds.
This is the most reversible stage. Fat loss, resistance training, post-meal walks, fiber, reduced refined carbohydrate. Consider berberine or inositol; metformin/GLP-1 if clinically appropriate.
- Fatty liver hiding behind a mildly raised ALT
ALT elevated · Triglycerides high · GGT up · HbA1c creeping · Central weight
Metabolic dysfunction-associated fatty liver — now the most common liver disease there is. It gets dismissed as "slightly high liver enzymes" for years while fibrosis accumulates silently.
5–10% body weight loss meaningfully reduces liver fat and is the single highest-yield intervention. Cut alcohol and fructose, raise protein. If ALT has been up for months, an ELF score answers "is there actual scarring" without a biopsy.
- Oxidative stress with the metabolic cause attached
F2-isoprostane high · hs-CRP up · HbA1c rising · Triglycerides high
F2-isoprostane is the most reliable oxidative stress measure available. Raised alongside metabolic markers, it is a consequence of the metabolic picture rather than a separate problem to buy antioxidants for.
Antioxidant supplements do not fix this and can blunt training adaptation. Blood sugar control, fat loss, sleep and stopping smoking move it. Fix the driver, retest in 3 months.
- Uric acid is a metabolic marker, not just a gout number
Uric acid high · Triglycerides high · Fasting insulin high · Blood pressure creeping
Insulin resistance reduces uric acid excretion by the kidney. So a raised urate is very often a metabolic signal arriving before anyone has a painful toe.
Treat the insulin resistance and urate usually follows. Cut fructose and alcohol (beer especially). Do not start urate-lowering drugs off one reading — that is a clinical decision with its own trade-offs.
Goals this panel helps decide
In the library: what moves these markers
Questions people ask
6 answered
- What blood tests are in the “Running Rapamycin (Sirolimus)” panel?
- 9 markers: Sirolimus, Whole Blood, Complete Blood Count (CBC) w/ Differential, Lipid Panel, ApoB (Apolipoprotein B), Comprehensive Metabolic Panel (CMP), HbA1c (Hemoglobin A1c), Insulin (Fasting), Urinalysis, Routine, hs-CRP (C-Reactive Protein, High Sensitivity).
- How much does the “Running Rapamycin (Sirolimus)” panel cost?
- $194.50 before the discount, $175.05 with code CAMERON, which the order button applies automatically. Marek's checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
- Do I need a doctor's order for these tests?
- No. These are ordered direct-to-consumer through Marek Diagnostics: you order online, walk into a Quest location, and results are emailed to you. No physician visit or insurance required. Not available in NY, NJ or RI.
- Does the “Running Rapamycin (Sirolimus)” panel diagnose anything?
- No. A panel measures; it does not diagnose. It tells you which numbers are worth a conversation with a clinician and which explanations the results make more or less likely. Compare every value against the range printed on your own report.
- When should I get the “Running Rapamycin (Sirolimus)” panel drawn?
- Fast 9-12 hours for the lipids, insulin and HbA1c. The sirolimus level is a trough: draw it immediately before your next dose, not after one. A level drawn the day after a weekly dose is not comparable to anything and cannot be used to adjust. Record the exact hours since the last dose on the requisition — without that number the level is uninterpretable. Do not draw within 2 weeks of an infection; this class suppresses the blood count and CRP at the same time.
- How do I read the “Running Rapamycin (Sirolimus)” panel results?
- Expected and manageable: triglycerides and ApoB up, a mild fall in white cells or platelets, unchanged glucose. Worth acting on: a platelet count falling across two draws, new protein in the urine, a fasting insulin and HbA1c rising together, or mouth ulcers that keep recurring. A drug level far below what the dose predicts usually means the product, not the person — and a level far above it means the dose interval is wrong for you, which is the single most useful thing this panel can tell somebody.
Your results, read properly
This page tells you what the panel measures and how to prepare. Skool is where your results get read and turned into a plan.
- Cam’s method for reading these results: which number to act on first, and what to retest
- The monthly Protocol Audit: your protocol read against your labs (a premium upgrade)
- Ask Cam live every Tuesday, 6pm Central
5.0 (15 reviews)1,500+ members

Want it built around you?
Educational and research purposes only. Not medical advice and not a diagnosis; a panel is a starting point for a conversation with a clinician, not a substitute for one. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure